NerissaC(Cowden)KreherMD

Chief Medical Officer for Rare Diseases at AVROBIO Inc.

Dr. Kreher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
702 Barnhill Dr
Indianapolis, IN 46202
Phone+1 317-274-1201

Fax+1 317-278-9905

Indiana University School of MedicineFellowship, Pediatric Endocrinology, 2002 - 2005
Indiana University School of MedicineResidency, Pediatrics, 1998 - 2002
Brody School of Medicine at East Carolina UniversityClass of 1998

PubMed

15 citations
Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
Ingrid Hansen-Pupp, Ann Hellström, Mohamed Hamdani, Adina Tocoian, Nerissa C. Kreher
Growth Hormone & IGF Research. 2017-10-01
10 citations
Development and verification of a pharmacokinetic model to optimize physiologic replacement of rhIGF-1/rhIGFBP-3 in preterm infants
Jou Ku Chung, Boubou Hallberg, Ingrid Hansen-Pupp, Martin A. Graham, Gerald J. Fetterly
Pediatric Research. 2017-03-01
21 citations
The High Direct Medical Costs of Prader-Willi Syndrome.
Andrew J. Shoffstall, Julia A. Gaebler, Nerissa C. Kreher, Timothy Niecko, Diah Douglas
The Journal of Pediatrics. 2016-08-01

Interview with an Industry CMO: Guest Nerissa Kreher – Episode 126September 3rd, 2024
BioSpace Movers & Shakers, Dec. 11December 10th, 2020
Entrada Therapeutics Strengthens Leadership Team with Key AppointmentsDecember 8th, 2020
Join now to see all